Auf dieser Seite
TNGX Tango Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$23,24
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,6952-Wochen-Tief
$34,3952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.91B
P/E (TTM)
-27.3
EPS (TTM)
$-0.85
Umsatz (TTM)
$54M
Ihre Abzeichen
52W-Spanne
$7–$34
Analystenbewertung
BUY
Kursziel
$45
P/E
-27.3
ROE
-21.3%
Nettogewinnmarge
-229.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
TNGX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$23.24
Marktkapitalisierung (MRQ)
$3.91B
P/E (TTM)
-27.3
EPS (TTM)
$-0.85
Umsatz (TTM)
$54M
ROE (TTM)
-21.3%
52W-Spanne
$7–$34
TNGX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Tango Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter137
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$62M2020-12-31 → 2025-12-31
EPS$-0.872021-12-31 → 2025-12-31
Freier Cashflow$-140M2021-12-31 → 2025-12-31
Nettogewinnmarge-229.9%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | TNGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -27.35-Jahres-Durchschnitt ≈-7.9 | ≈-7.9 | · | · | |
| P/S (TTM) | 72.75-Jahres-Durchschnitt ≈21.3 | ≈21.3 | 246.4 | Unterbewertet | |
| K/B (MRQ) | 3.85-Jahres-Durchschnitt ≈2.9 | ≈2.9 | 4.6 | Überbewertet | |
| Kurs / FCF (TTM) | -27.15-Jahres-Durchschnitt ≈-8.1 | ≈-8.1 | · | · | |
| Kurs / Cashflow (TTM) | -27.25-Jahres-Durchschnitt ≈-8.3 | ≈-8.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 9.15-Jahres-Durchschnitt ≈2.9 | ≈2.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | TNGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -253.4%5-Jahres-Durchschnitt ≈-288.2% | ≈-288.2% | -8739.3% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -178.4%5-Jahres-Durchschnitt ≈-288.2% | ≈-288.2% | -8739.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -230.0%5-Jahres-Durchschnitt ≈-268.3% | ≈-268.3% | · | · | |
| Nettogewinnmarge (TTM) | -229.9%5-Jahres-Durchschnitt ≈-268.7% | ≈-268.7% | -7973.3% | Spitzenklasse | |
| ROA (TTM) | -18.9%5-Jahres-Durchschnitt ≈-25.7% | ≈-25.7% | -35.9% | Spitzenklasse | |
| ROE (TTM) | -21.3%5-Jahres-Durchschnitt ≈-39.8% | ≈-39.8% | -42.2% | Im Einklang | |
| ROIC | -32.1%5-Jahres-Durchschnitt ≈-42.4% | ≈-42.4% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | TNGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 50.85-Jahres-Durchschnitt ≈9.9 | ≈9.9 | 14.2 | Starke Liquidität | |
| Quick Ratio | 15.85-Jahres-Durchschnitt ≈9.7 | ≈9.7 | 9.4 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | TNGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 48.3%5-Jahres-Durchschnitt ≈92.3% | ≈92.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 35.9%5-Jahres-Durchschnitt ≈36.2% | ≈36.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 52.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | TNGX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.25-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$455.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
59.6%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.37 | $-0.32 | -13.9% |
| 31. März 2026 | Mai 13, 2026 | $-0.32 | $-0.32 | -0.13% |
| 31. Dezember 2025 | $-0.29 | $-0.33 | 11.2% | |
| 30. September 2025 | $0.14 | $-0.05 | 360.2% | |
| 30. Juni 2025 | $-0.35 | $-0.35 | 1.4% | |
| 31. März 2025 | $-0.36 | $-0.36 | -0.84% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $62M | $42M | $37M | $25M | $37M | $8M | |
| R&D Expense | $132M | $144M | $115M | $106M | $78M | $50M | |
| SG&A Expense | $42M | $44M | $36M | $30M | $18M | $10M | |
| Operating Expenses | $174M | $188M | $151M | $136M | $95M | $60M | |
| Operating Income | $-111M | $-146M | $-114M | $-111M | $-58M | $-52M | |
| Other Non-op | $4M | $8M | $6M | $1M | $-248.0K | $120.0K | |
| Pretax Income | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| Income Tax | $4.0K | $208.0K | $134.0K | $54.0K | $292.0K | $0 | |
| Net Income | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| EPS (Basic) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | · | |
| EPS (Diluted) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | · | |
| Shares (Basic) | 116,166,187 | 109,226,731 | 94,572,448 | 87,820,037 | 62,108,032 | · | |
| Shares (Diluted) | 116,166,187 | 109,226,731 | 94,572,448 | 87,820,037 | 62,108,032 | · | |
| EBITDA | $-111M | $-146M | $-114M | $-111M | $-58M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $70M | $66M | $60M | $143M | $28M | |
| Short-term Investments | $231M | $188M | $270M | $306M | $343M | $162M | |
| Receivables | · | · | · | $2M | $2M | $2M | |
| Prepaid Expense | $10M | $8M | $9M | $7M | $5M | $1M | |
| Current Assets | $354M | $266M | $347M | $375M | $492M | $194M | |
| PP&E (Net) | $7M | $8M | $10M | $11M | $5M | $4M | |
| PP&E (Gross) | $17M | $16M | $16M | $15M | $7M | $6M | |
| Accum. Depreciation | $11M | $8M | $6M | $4M | $3M | $2M | |
| Other Non-current Assets | $303.0K | $4.0K | $46.0K | $5.0K | $19.0K | $38.0K | |
| Total Assets | $399M | $316M | $403M | $436M | $500M | $207M | |
| Accounts Payable | $1M | $2M | $3M | $4M | $3M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $74.9K | |
| Current Liabilities | $22M | $38M | $46M | $56M | $41M | $41M | |
| Capital Leases | $31M | $34M | $37M | $39M | · | $7M | |
| Other Non-current Liabilities | · | · | · | · | · | $5.0K | |
| Total Liabilities | $53M | $117M | $149M | $187M | $155M | $169M | |
| Common Stock | $136.0K | $108.0K | $102.0K | $88.0K | $88.0K | $40.0K | |
| Paid-in Capital | $949M | $701M | $624M | $523M | $507M | $142M | |
| Retained Earnings | $-603M | $-502M | $-371M | $-270M | $-161M | $-103M | |
| AOCI | $224.0K | $336.0K | $186.0K | $-4M | $-765.0K | $17.0K | |
| Stockholders' Equity | $346M | $200M | $253M | $249M | $345M | $39M | |
| Liabilities + Equity | $399M | $316M | $403M | $436M | $500M | $207M | |
| Shares Outstanding | 135,940,454 | 107,729,343 | 102,202,759 | 88,179,374 | 87,598,184 | 40,372,133 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $29M | $19M | $14M | $8M | $2M | |
| Operating Cash Flow | $-139M | $-132M | $-118M | $-109M | $-60M | $70M | |
| CapEx | $1M | $754.0K | $2M | $8M | $2M | $1M | |
| Investing Cash Flow | $-41M | $86M | $41M | $26M | $-183M | $-145M | |
| Financing Cash Flow | $222M | $48M | $82M | $2M | $357M | $81M | |
| Net Change in Cash | $43M | $2M | $6M | $-81M | $114M | $5M | |
| Taxes Paid | $12.0K | · | · | · | · | · | |
| Free Cash Flow | $-140M | $-132M | $-120M | $-117M | $-61M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | · | |
| Net Margin | -162.8% | -309.7% | -278.5% | -435.1% | -157.2% | · | |
| Pretax Margin | -162.8% | -309.2% | -278.2% | -434.9% | -156.4% | · | |
| EBITDA Margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | · | |
| ROA | -28.4% | -36.2% | -24.2% | -23.1% | -16.5% | · | |
| ROE | -42.2% | -60.8% | -38.4% | -41.4% | -16.4% | · | |
| ROIC | -32.1% | -73.1% | -45.2% | -44.5% | -17.0% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 7.0 | 7.5 | 6.8 | 12.1 | 13.1 | |
| Quick Ratio | 15.8 | 6.8 | 7.3 | 6.6 | 12.0 | 11.5 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | · | 12.4 | 18.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.55 | $1.85 | $2.48 | $2.83 | $3.94 | $0.89 | |
| Revenue / Share | $0.54 | $0.39 | $0.39 | $0.28 | · | · | |
| Cash Flow / Share | $-1.20 | $-1.20 | $-1.25 | $-1.24 | · | · | |
| Cash / Share | $0.83 | $0.65 | $0.65 | $0.68 | $1.63 | $0.23 | |
| EPS (TTM) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.3% | 15.2% | 46.9% | -32.9% | 383.8% | · | |
| Revenue CAGR 3Y | 35.9% | 4.3% | 68.3% | · | · | · | |
| Revenue CAGR 5Y | 52.1% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $62M | $42M | $37M | $25M | $37M | $8M | |
| Net Income TTM | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| Market Cap | $1.20B | $333M | $1.01B | $639M | $958M | $65M | |
| P/E | -10.2 | -2.6 | -9.2 | -5.9 | -11.6 | · | |
| P/S | 19.3 | 7.9 | 27.7 | 25.7 | 25.9 | 8.4 | |
| P/B | 3.5 | 1.7 | 4.0 | 2.6 | 2.8 | 12.9 | |
| P / Tangible Book | 3.5 | 1.7 | 4.0 | 2.6 | 2.8 | 1.7 | |
| P / Cash Flow | -8.7 | -2.5 | -8.6 | -5.9 | -16.1 | · | |
| P / FCF | -8.6 | -2.5 | -8.5 | -5.5 | -15.6 | · | |
| Earnings Yield | -9.8% | -38.5% | -10.9% | -17.0% | -8.6% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $54M | $3M | $5M | $4M | $12M | $20M | $6M | $5M | $11M | $15M | $6M | $6M | $7M | |
| R&D Expense | $37M | $34M | $32M | $31M | $33M | $36M | $34M | $33M | $39M | $38M | $31M | $27M | $29M | $28M | $29M | $29M | |
| SG&A Expense | $23M | $15M | $10M | $9M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | |
| Operating Expenses | $60M | $49M | $42M | $40M | $44M | $48M | $45M | $44M | $49M | $49M | $40M | $36M | $38M | $36M | $37M | $37M | |
| Operating Income | $-60M | $-49M | $-42M | $14M | $-41M | $-43M | $-41M | $-33M | $-30M | $-42M | $-35M | $-26M | $-23M | $-30M | $-31M | $-30M | |
| Other Non-op | $722.0K | $1M | $1M | $705.0K | $910.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $967.0K | $523.0K | |
| Pretax Income | $-55M | $-46M | $-39M | $16M | $-39M | $-40M | $-38M | $-29M | $-25M | $-38M | $-31M | $-22M | $-21M | $-28M | $-29M | $-29M | |
| Income Tax | $1.0K | $1.0K | $-55.0K | $-10.0K | $35.0K | $34.0K | $49.0K | $54.0K | $65.0K | $40.0K | $47.0K | $23.0K | $64.0K | $0 | $51.0K | $0 | |
| Net Income | $-55M | $-46M | $-39M | $16M | $-39M | $-40M | $-38M | $-29M | $-26M | $-38M | $-31M | $-22M | $-21M | $-28M | $-29M | $-29M | |
| EPS (Basic) | $-0.37 | $-0.32 | $-0.30 | $0.14 | $-0.35 | $-0.36 | $-0.33 | $-0.27 | $-0.24 | $-0.35 | $-0.30 | $-0.23 | $-0.23 | $-0.32 | $-0.33 | $-0.33 | |
| EPS (Diluted) | $-0.37 | $-0.32 | $-0.29 | $0.13 | $-0.35 | $-0.36 | $-0.33 | $-0.27 | $-0.24 | $-0.35 | $-0.30 | $-0.23 | $-0.23 | $-0.32 | $-0.33 | $-0.33 | |
| Shares (Basic) | 149,875,939 | 143,576,292 | · | 110,966,345 | 110,540,836 | 110,301,256 | · | 108,507,390 | 108,314,279 | 108,171,463 | · | 97,033,273 | 88,354,590 | 88,193,917 | · | 87,892,195 | |
| Shares (Diluted) | 149,875,939 | 143,576,292 | · | 117,782,074 | 110,540,836 | 110,301,256 | · | 108,507,390 | 108,314,279 | 108,171,463 | · | 97,033,273 | 88,354,590 | 88,193,917 | · | 87,892,195 | |
| EBITDA | $-60M | $-49M | · | $14M | $-41M | $-43M | · | $-33M | $-30M | $-42M | · | $-26M | $-23M | $-30M | · | $-30M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $346M | $158M | $112M | $58M | $39M | $58M | $70M | $53M | $52M | $61M | $66M | $59M | $66M | $57M | $60M | $100M | |
| Short-term Investments | $668M | $222M | $231M | $94M | $142M | $158M | $188M | $240M | $271M | $282M | · | $301M | $245M | $276M | · | $293M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Prepaid Expense | $18M | $12M | $10M | $11M | $9M | $8M | $8M | $8M | $6M | $8M | · | $10M | $9M | $9M | · | $6M | |
| Current Assets | $1.03B | $392M | $354M | $164M | $190M | $225M | $266M | $301M | $328M | $352M | · | $371M | $321M | $343M | · | $402M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $10M | · | $10M | $11M | $11M | · | $11M | |
| PP&E (Gross) | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | $16M | · | $16M | $16M | $15M | · | $14M | |
| Accum. Depreciation | $11M | $11M | $11M | $10M | $10M | $9M | $8M | $8M | $7M | $7M | · | $5M | $5M | $4M | · | $3M | |
| Other Non-current Assets | $312.0K | $293.0K | $303.0K | $290.0K | $310.0K | $1.0K | $4.0K | $13.0K | $10.0K | $11.0K | · | $48.0K | $12.0K | $19.0K | · | $6.0K | |
| Total Assets | $1.07B | $436M | $399M | $210M | $238M | $274M | $316M | $352M | $381M | $406M | · | $428M | $379M | $404M | · | $464M | |
| Accounts Payable | $2M | $2M | $1M | $2M | $3M | $3M | $2M | $4M | $1M | $4M | · | $3M | $5M | $6M | · | $6M | |
| Current Liabilities | $20M | $14M | $22M | $18M | $40M | $36M | $38M | $38M | $44M | $43M | · | $43M | $54M | $54M | · | $51M | |
| Capital Leases | $29M | $30M | $31M | $32M | $32M | $34M | $34M | $35M | $35M | $36M | · | $37M | $38M | $39M | · | $40M | |
| Total Liabilities | $49M | $44M | $53M | $50M | $103M | $108M | $117M | $123M | $134M | $142M | · | $152M | $166M | $177M | · | $191M | |
| Common Stock | $168.0K | $144.0K | $136.0K | $112.0K | $111.0K | $108.0K | $108.0K | $107.0K | $107.0K | $107.0K | · | $102.0K | $88.0K | $88.0K | · | $88.0K | |
| Paid-in Capital | $1.73B | $1.04B | $949M | $724M | $715M | $708M | $701M | $692M | $683M | $674M | · | $618M | $533M | $527M | · | $518M | |
| Retained Earnings | $-704M | $-649M | $-603M | $-564M | $-580M | $-541M | $-502M | $-464M | $-435M | $-409M | · | $-340M | $-318M | $-298M | · | $-240M | |
| AOCI | $-633.0K | $-115.0K | $224.0K | $121.0K | $94.0K | $194.0K | $336.0K | $750.0K | $-334.0K | $-257.0K | · | $-681.0K | $-2M | $-2M | · | $-5M | |
| Stockholders' Equity | $1.02B | $392M | $346M | $160M | $135M | $167M | $200M | $229M | $248M | $264M | $253M | $277M | $213M | $227M | $249M | $273M | |
| Liabilities + Equity | $1.07B | $436M | $399M | $210M | $238M | $274M | $316M | $352M | $381M | $406M | · | $428M | $379M | $404M | · | $464M | |
| Shares Outstanding | 168,380,091 | 144,162,543 | 135,940,454 | 111,567,062 | 110,871,249 | 108,107,890 | 107,729,343 | 107,414,636 | 107,044,240 | 106,730,785 | · | 101,847,154 | 88,462,844 | 88,209,964 | · | 88,067,254 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $11M | $6M | $7M | $7M | $7M | $7M | $7M | $8M | $7M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Operating Cash Flow | $-39M | $-44M | $-30M | $-31M | $-37M | $-42M | $-37M | $-33M | $-24M | $-38M | $-27M | $-31M | $-24M | $-35M | $-28M | $-20M | |
| CapEx | $-20.0K | $-2.0K | $222.0K | $151.0K | $624.0K | $51.0K | $124.0K | $115.0K | $320.0K | $195.0K | $226.0K | $16.0K | $664.0K | $620.0K | $1M | $3M | |
| Investing Cash Flow | $-446M | $10M | $-136M | $47M | $17M | $31M | $52M | $33M | $13M | $-11M | $34M | $-57M | $33M | $32M | $-13M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $42M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $42M | · | · | · | · | · | · | |
| Financing Cash Flow | $673M | $80M | $219M | $3M | $581.0K | $2.0K | $969.0K | $2M | $1M | $43M | $1M | $80M | $586.0K | $73.0K | $527.0K | $113.0K | |
| Net Change in Cash | $188M | $45M | $54M | $19M | $-19M | $-11M | $16M | $2M | $-10M | $-6M | $8M | $-8M | $9M | $-3M | $-40M | $-4M | |
| Free Cash Flow | · | $-44M | · | · | · | $-42M | · | · | · | $-38M | · | · | · | $-36M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | 26.2% | -1287.9% | -788.8% | · | -283.3% | -148.7% | -653.0% | · | -238.8% | -159.2% | -525.2% | · | -432.4% | |
| Net Margin | · | · | · | 29.5% | -1221.4% | -739.5% | · | -251.3% | -128.6% | -585.9% | · | -207.4% | -141.9% | -485.7% | · | -419.8% | |
| Pretax Margin | · | · | · | 29.5% | -1220.3% | -738.9% | · | -250.8% | -128.2% | -585.3% | · | -207.2% | -141.4% | · | · | -419.8% | |
| EBITDA Margin | · | · | · | 26.2% | -1287.9% | -788.8% | · | -283.3% | -148.7% | -653.0% | · | -238.8% | -159.2% | -525.2% | · | -432.4% | |
| ROA | -8.4% | -12.8% | · | 5.7% | -12.6% | -11.7% | · | -7.5% | -6.7% | -9.4% | · | -5.0% | -5.0% | -6.4% | · | -5.8% | |
| ROE | -9.6% | -16.3% | · | 8.2% | -20.3% | -18.5% | · | -11.5% | -11.1% | -15.4% | · | -8.1% | -8.1% | -10.2% | · | -9.1% | |
| ROIC | -5.8% | -12.5% | · | 8.8% | -30.4% | -25.5% | · | -14.4% | -12.0% | -16.0% | · | -9.3% | -10.9% | · | · | -11.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 50.8 | 27.4 | · | 8.9 | 4.7 | 6.3 | · | 8.0 | 7.5 | 8.2 | · | 8.5 | 6.0 | 6.4 | · | 7.8 | |
| Quick Ratio | 50.0 | 26.5 | · | 8.3 | 4.5 | 6.0 | · | 7.8 | 7.3 | 8.0 | · | 8.3 | 5.8 | 6.2 | · | 7.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.08 | $2.72 | · | $1.43 | $1.22 | $1.54 | · | $2.13 | $2.31 | $2.48 | · | $2.72 | $2.41 | $2.58 | · | $3.10 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.46 | $0.03 | $0.05 | · | $0.11 | $0.18 | $0.06 | · | $0.11 | $0.17 | $0.07 | · | $0.08 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.38 | · | · | · | $-0.35 | · | · | · | $-0.40 | · | · | |
| Cash / Share | $2.05 | $1.09 | · | $0.52 | $0.35 | $0.54 | · | $0.49 | $0.48 | $0.57 | · | $0.57 | $0.75 | $0.65 | · | $1.14 | |
| EPS (TTM) | $-0.85 | $-0.83 | · | $-0.91 | $-1.31 | $-1.20 | · | $-1.16 | $-1.12 | $-1.11 | · | $-1.11 | $-1.21 | $-1.26 | · | $-1.16 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $57M | · | $66M | $24M | $41M | · | $43M | $43M | $37M | · | $38M | $34M | $25M | · | $24M | |
| Net Income TTM | $-124M | $-107M | · | $-101M | $-146M | $-132M | · | $-123M | $-116M | $-112M | · | $-100M | $-107M | $-111M | · | $-101M | |
| Market Cap | $5.26B | $3.02B | · | $937M | $568M | $148M | · | $827M | $918M | $847M | · | $1.15B | $294M | $348M | · | $319M | |
| P/E | -36.8 | -25.2 | · | -9.2 | -3.9 | -1.1 | · | -6.6 | -7.7 | -7.2 | · | -10.1 | -2.7 | -3.1 | · | -3.1 | |
| P/S | 97.8 | 52.9 | · | 14.1 | 23.4 | 3.6 | · | 19.1 | 21.6 | 22.8 | · | 30.6 | 8.7 | 14.0 | · | 13.2 | |
| P/B | 5.1 | 7.7 | · | 5.9 | 4.2 | 0.9 | · | 3.6 | 3.7 | 3.2 | · | 4.1 | 1.4 | 1.5 | · | 1.2 | |
| P / Tangible Book | 5.1 | 7.7 | · | 5.9 | 4.2 | 0.9 | · | 3.6 | 3.7 | 3.2 | · | 4.1 | 1.4 | 1.5 | · | 1.2 | |
| P / Cash Flow | · | -68.0 | · | · | · | -3.6 | · | · | · | -22.4 | · | · | · | -10.0 | · | · | |
| Earnings Yield | -2.7% | -4.0% | · | -10.8% | -25.6% | -87.6% | · | -15.1% | -13.1% | -14.0% | · | -9.9% | -36.4% | -31.9% | · | -32.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $62M | $42M | $37M | $25M | $37M |
| Betriebsgewinnmarge % | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% |
| Nettoergebnis | $-102M | $-130M | $-102M | $-108M | $-58M |
| Verwässerte EPS | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 16.3 | 7.0 | 7.5 | 6.8 | 12.1 |
| Quick Ratio | 15.8 | 6.8 | 7.3 | 6.6 | 12.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-140M | $-132M | $-120M | $-117M | $-61M |
Institutionelle Eigentümer (13F) 259 Einreicher · $6.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
259
Gehaltener Wert
$6.3B
Neue Positionen
77
Geschlossene Positionen
22
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 77 (+15 vs. Vorquartal) | 22 (-8 vs. Vorquartal) | 105 (+40 vs. Vorquartal) | 54 (0 vs. Vorquartal) | +38.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $434.533.381 | 13.900.620 | 6,87% | Aktien |
| BlackRock, Inc. | $388.825.760 | 12.438.444 | 6,15% | Aktien |
| FMR LLC | $385.540.161 | 12.333.339 | 6,10% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $383.779.020 | 12.277.000 | 6,07% | Aktien |
| Boxer Capital Management, LLC | $339.990.606 | 10.876.219 | 5,38% | Aktien |
| GOLDMAN SACHS GROUP INC | $311.994.191 | 9.980.620 | 4,94% | Aktien |
| TCG Crossover Management, LLC | $283.878.343 | 9.081.201 | 4,49% | Aktien |
| Paradigm Biocapital Advisors LP | $198.736.169 | 6.357.523 | 3,14% | Aktien |
| Siren, L.L.C. | $193.166.919 | 6.179.364 | 3,06% | Aktien |
| STATE STREET CORP | $186.928.736 | 5.979.806 | 2,96% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $186.226.699 | 5.957.348 | 2,95% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $175.056.000 | 5.600.000 | 2,77% | Aktien |
| Deep Track Capital, LP | $131.292.000 | 4.200.000 | 2,08% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $130.998.500 | 4.190.611 | 2,07% | Aktien |
| Woodline Partners LP | $125.057.724 | 4.000.567 | 1,98% | Aktien |
| TRV GP IV, LLC | $120.181.383 | 6.374.574 | 1,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $117.021.411 | 3.742.791 | 1,85% | Aktien |
| PERCEPTIVE ADVISORS LLC | $105.565.020 | 3.377.000 | 1,67% | Aktien |
| Seven Fleet Capital Management LP | $95.660.985 | 3.228.144 | 1,51% | Aktien |
| Logos Global Management LP | $89.091.000 | 2.850.000 | 1,41% | Aktien |
| Caligan Partners LP | $78.153.220 | 2.500.103 | 1,24% | Aktien |
| Holocene Advisors, LP | $75.365.953 | 2.410.939 | 1,19% | Aktien |
| Commodore Capital LP | $70.335.000 | 2.250.000 | 1,11% | Aktien |
| Balyasny Asset Management L.P. | $63.032.008 | 2.016.379 | 1,00% | Aktien |
| Jefferies Financial Group Inc. | $62.849.293 | 2.010.534 | 0,99% | Aktien |
| VANGUARD GROUP INC | $59.813.655 | 6.750.977 | 0,95% | Aktien |
| FRANKLIN RESOURCES INC | $58.994.217 | 1.887.211 | 0,93% | Aktien |
| Candriam S.C.A. | $50.922.046 | 1.630.553 | 0,81% | Aktien |
| JANUS HENDERSON GROUP PLC | $50.066.890 | 2.394.972 | 0,79% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $49.550.570 | 1.585.111 | 0,78% | Aktien |
| JPMORGAN CHASE & CO | $46.318.195 | 1.418.193 | 0,73% | Aktien |
| Polar Capital Holdings Plc | $46.287.932 | 1.480.740 | 0,73% | Aktien |
| Vivo Capital, LLC | $43.131.579 | 1.379.769 | 0,68% | Aktien |
| DV EQUITIES, LLC | $41.217.904 | 1.318.551 | 0,65% | Aktien |
| Cormorant Asset Management, LP | $40.638.000 | 1.300.000 | 0,64% | Aktien |
| NORTHERN TRUST CORP | $38.510.226 | 1.231.933 | 0,61% | Aktien |
| STEMPOINT CAPITAL LP | $38.231.574 | 1.223.019 | 0,60% | Aktien |
| FEDERATED HERMES, INC. | $37.968.802 | 1.214.613 | 0,60% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $34.480.718 | 1.103.030 | 0,55% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $33.512.564 | 1.072.059 | 0,53% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $31.691.245 | 1.013.794 | 0,50% | Aktien |
| Integral Health Asset Management, LLC | $31.260.000 | 1.000.000 | 0,49% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $28.620.562 | 915.565 | 0,45% | Aktien |
| Nuveen, LLC | $27.826.714 | 890.170 | 0,44% | Aktien |
| SAMLYN CAPITAL, LLC | $23.959.946 | 766.473 | 0,38% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $23.391.858 | 748.300 | 0,37% | Aktien |
| Soleus Capital Management, L.P. | $22.163.340 | 709.000 | 0,35% | Aktien |
| ArrowMark Colorado Holdings LLC | $22.144.115 | 708.385 | 0,35% | Aktien |
| Bellevue Group AG | $21.700.129 | 694.182 | 0,34% | Aktien |
| Alyeska Investment Group, L.P. | $21.604.067 | 691.109 | 0,34% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Third Rock Ventures IV, L.P., Third Rock Ventures GP IV, L.P., TRV GP IV, LLC ×3 Einreichungen | 10. Februar 2026 | 4,74% | Änderung | · | SEC |
| BCTG Holdings, LLC, MVA Investors, LLC, Davis Aaron I., Boxer Capital Management, LLC ×7 Einreichungen | 2. Januar 2025 | 10,00% | Änderung | · | SEC |
| Boxer Asset Management Inc., Braslyn Ltd., Joe Lewis | 15. Oktober 2024 | · | Erste Einreichung | · | SEC |
| Boxer Capital Management, LLC, Boxer Capital, LLC, MVA Investors, LLC, Aaron I. Davis | 15. Oktober 2024 | · | Erste Einreichung | · | SEC |
| Third Rock Ventures IV, L.P. (2), Third Rock Ventures GP IV, L.P. (2), TRV GP IV, LLC (2) ×2 Einreichungen | 4. September 2024 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 20 Insider · 9 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Malte Peters | President & CEO | 8. Januar 2026 A | 367.500 | 0 | 0 | $0 |
| Matthew Gall | Chief Financial Officer | 1. Mai 2026 A | 40.000 | 0 | 0 | $0 |
| Daniella Beckman | Chief Financial Officer | 2. Februar 2026 A | 184.297 | 0 | 2 | $-126.559 |
| Adam Crystal | President, R&D | 1. September 2026 M | 115.743 | 0 | 16 | $-6.328.368 |
| Jessica Newcomb | Principal Accounting Officer | 22. September 2026 S | 59.121 | 0 | 3 | $-198.615 |
| Barbara Weber | Director, Executive Chair | 2. Februar 2026 A | 1.629.254 | 0 | 2 | $-374.376 |
| Douglas Barry | General Counsel | 5. Februar 2025 S | 66.014 | 0 | 0 | $0 |
| Alan Huang | Chief Scientific Officer | 1. März 2023 A | 167.584 | 0 | 0 | $0 |
| Marc Rudoltz | Chief Medical Officer | 1. November 2021 A | · | 0 | 0 | $0 |
| Robert Azelby | Direktor | 19. Juni 2026 A | 5.740 | 0 | 0 | $0 |
| John B Ketchum | Direktor | 5. Juni 2026 A | 24.937 | 0 | 0 | $0 |
| Mace Rothenberg | Direktor | 5. Juni 2026 A | 41.500 | 0 | 0 | $0 |
| Sung Lee | Direktor | 5. Juni 2026 A | 22.870 | 0 | 0 | $0 |
| Lesley Ann Calhoun | Direktor | 5. Juni 2026 A | 16.500 | 0 | 0 | $0 |
| Alexis Borisy | Direktor | 5. Juni 2025 A | 17.500 | 0 | 0 | $0 |
| Reid M Huber | Direktor | 6. Juni 2023 A | 5.000 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10%-Eigentümer | 7. November 2024 S | 10.630.736 | 0 | 0 | $0 |
| Davis Aaron I. | · | 3. September 2024 J | 5.000 | 0 | 0 | $0 |
| Aaron Weitzman | · | 1. Dezember 2022 A | · | 0 | 0 | $0 |
| BCTG Holdings, LLC | · | 20. November 2020 S | 4.488.450 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 33 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,59% | 10.046 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,54% | 97.971 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,47% | 224.575 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,28% | 11.928 SH | 2. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,26% | 150.730 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,23% | 146.692 SH | 19. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,22% | 111.623 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,22% | 1.321.158 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,21% | 910.926 SH | 11. September 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,17% | 80.173 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,15% | 1.338 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,13% | 810.623 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,12% | 67.434 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,11% | 3.600.624 SH | 11. September 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,10% | 3.292 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 25.464 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 20.345 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 29.532 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 60.441 SH | 2. Oktober 2026 | Täglich |
| ESML · iShares Trust | 0,05% | 59.086 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.418.754 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 281.272 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 44.480 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 6.262 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 61.068 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 4.396.603 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.571 SH | 19. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 40.191 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 151.712 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 4.480 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.276 NS | 31. Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 17 SH | 2. Oktober 2026 | Täglich |
| ISCB · iShares Trust | · | 4.243 SH | 11. September 2026 | Täglich |
TNGX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$40.00
+72,1%
8 42,1%
Starker Kauf
9 47,4%
Kauf
2 10,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-10-01Mittelwert-Ziel $45.18 +94,4%
← Unter allen Zielen
Aktueller Preis $23.24
Tief$24.00
Mittelwert$45.18
Hoch$69.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026